$INSY Still circling the wagons around the $9/share value. Not a Bad week but certainly NOT a Good week for share price. The $9/share barrier has been difficult to successfully pass and then maintain. This MAY be due to Press Releases with respect to the 'Opioid Crisis'. Insys Therapeutics is still a part of the Press Release equation and will continue to face many questions. The constant Media coverage seems to contribute to the slower growth of the share price.
The Good News remains that INSYS has continued with its R&D Program and is actively developing new products for FDA review/trials. Additionally, INSYS has entered into a new and large Market in the Middle East. The R&D and the Middle East Market will take Time AND Patience to develop AND expand. To me, The Future looks very promising for Insy Share Price because the company should continue to grow.
(0)
(0)
Insys Therapeutics Inc. (INSYQ) Stock Research Links